NCT01434316 2026-03-18Veliparib and Dinaciclib in Treating Patients With Advanced Solid TumorsNational Cancer Institute (NCI)Phase 1 Active not recruiting121 enrolled
NCT01591356 2026-01-07EphA2 siRNA in Treating Patients With Advanced or Recurrent Solid TumorsM.D. Anderson Cancer CenterPhase 1 Active not recruiting49 enrolled